
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $97.5M | $122.8M | $157.1M | $185.5M | $209.9M | |
Revenue Growth (YoY) | 7.6% | 25.98% | 27.93% | 18.09% | 13.13% | |
Cost of Revenues | $77M | $113.7M | $131.7M | $144.9M | $157M | |
Gross Profit | $20.5M | $9.1M | $25.4M | $40.6M | $52.9M | |
Gross Profit Margin | 21% | 7.43% | 16.17% | 21.88% | 25.18% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $17.5M | $20.4M | $23.1M | $32.2M | $37.1M | |
Other Inc / (Exp) | $113K | $527K | $250K | -$1.1M | -$364K | |
Operating Expenses | $17.5M | $20.5M | $24.2M | $33.7M | $37.7M | |
Operating Income | $3M | -$11.3M | $1.3M | $6.9M | $15.2M | |
Net Interest Expenses | -- | $400K | $939K | $248K | -- | |
EBT. Incl. Unusual Items | $3.3M | -$11.2M | $561K | $5.6M | $15.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $893K | -$2.4M | $194K | $1M | $3.2M | |
Net Income to Company | $2.4M | -$8.8M | $367K | $4.6M | $12.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $2.4M | -$8.8M | $367K | $4.6M | $12.2M | |
Basic EPS (Cont. Ops) | $0.24 | -$0.83 | $0.03 | $0.42 | $1.12 | |
Diluted EPS (Cont. Ops) | $0.24 | -$0.83 | $0.03 | $0.42 | $1.11 | |
Weighted Average Basic Share | $10M | $10.5M | $10.6M | $10.7M | $10.9M | |
Weighted Average Diluted Share | $10M | $10.5M | $10.7M | $10.8M | $11.1M | |
EBITDA | $5.2M | -$5.2M | $7.2M | $12.4M | $21.1M | |
EBIT | $3.3M | -$10.8M | $1.3M | $6.9M | $15.2M | |
Revenue (Reported) | $97.5M | $122.8M | $157.1M | $185.5M | $209.9M | |
Operating Income (Reported) | $3M | -$11.3M | $1.3M | $6.9M | $15.2M | |
Operating Income (Adjusted) | $3.3M | -$10.8M | $1.3M | $6.9M | $15.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $25.7M | $39.7M | $43M | $49.1M | $59.3M | |
Revenue Growth (YoY) | 11.22% | 54.79% | 8.28% | 14.05% | 20.94% | |
Cost of Revenues | $20.7M | $35.5M | $35.9M | $36.4M | $43.3M | |
Gross Profit | $5M | $4.2M | $7.2M | $12.7M | $16M | |
Gross Profit Margin | 19.4% | 10.6% | 16.63% | 25.87% | 26.98% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $4.4M | $5.9M | $7.2M | $10.7M | $10.3M | |
Other Inc / (Exp) | -$51K | $111K | $62K | -$94K | -$91K | |
Operating Expenses | $4.4M | $6.3M | $7.5M | $11.2M | $10.5M | |
Operating Income | $601K | -$2.1M | -$352K | $1.5M | $5.5M | |
Net Interest Expenses | -- | $143K | $242K | -- | -- | |
EBT. Incl. Unusual Items | $572K | -$2.1M | -$532K | $1.5M | $5.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $184K | -$657K | -$51K | $119K | $1.2M | |
Net Income to Company | $388K | -$1.4M | -$481K | $1.3M | $4.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $388K | -$1.4M | -$481K | $1.3M | $4.4M | |
Basic EPS (Cont. Ops) | $0.04 | -$0.13 | -$0.05 | $0.12 | $0.40 | |
Diluted EPS (Cont. Ops) | $0.04 | -$0.13 | -$0.05 | $0.12 | $0.40 | |
Weighted Average Basic Share | $10M | $10.6M | $10.6M | $10.8M | $10.9M | |
Weighted Average Diluted Share | $10M | $10.6M | $10.7M | $11M | $11.2M | |
EBITDA | $1.1M | -$380K | $979K | $3.1M | $7.1M | |
EBIT | $574K | -$2M | -$540K | $1.5M | $5.5M | |
Revenue (Reported) | $25.7M | $39.7M | $43M | $49.1M | $59.3M | |
Operating Income (Reported) | $601K | -$2.1M | -$352K | $1.5M | $5.5M | |
Operating Income (Adjusted) | $574K | -$2M | -$540K | $1.5M | $5.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $97.5M | $122.8M | $157.1M | $185.5M | $209.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $77M | $113.7M | $131.7M | $144.9M | $157M | |
Gross Profit | $20.5M | $9.1M | $25.4M | $40.6M | $52.9M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $17.5M | $20.4M | $23.1M | $32.2M | $37.1M | |
Other Inc / (Exp) | $113K | $527K | $250K | -$1.1M | -$364K | |
Operating Expenses | $17.5M | $20.5M | $24.2M | $33.7M | $37.7M | |
Operating Income | $3M | -$11.3M | $1.3M | $6.9M | $15.2M | |
Net Interest Expenses | -- | $400K | $939K | $248K | -- | |
EBT. Incl. Unusual Items | $3.3M | -$11.2M | $561K | $5.6M | $15.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $893K | -$2.4M | $194K | $1M | $3.2M | |
Net Income to Company | $2.4M | -$8.8M | $367K | $4.6M | $12.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $2.4M | -$8.8M | $367K | $4.6M | $12.2M | |
Basic EPS (Cont. Ops) | $0.24 | -$0.84 | $0.02 | $0.43 | $1.12 | |
Diluted EPS (Cont. Ops) | $0.24 | -$0.84 | $0.02 | $0.43 | $1.11 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $5.2M | -$5.2M | $7.2M | $12.4M | $21.1M | |
EBIT | $3.3M | -$10.8M | $1.3M | $6.9M | $15.2M | |
Revenue (Reported) | $97.5M | $122.8M | $157.1M | $185.5M | $209.9M | |
Operating Income (Reported) | $3M | -$11.3M | $1.3M | $6.9M | $15.2M | |
Operating Income (Adjusted) | $3.3M | -$10.8M | $1.3M | $6.9M | $15.2M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Revenue | $122.8M | $157.1M | $185.5M | $209.9M | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $113.7M | $131.7M | $144.9M | $157M | -- | |
Gross Profit | $9.1M | $25.4M | $40.6M | $52.9M | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $20.4M | $23.1M | $32.2M | $37.1M | -- | |
Other Inc / (Exp) | $527K | $250K | -$1.1M | -$364K | -- | |
Operating Expenses | $20.5M | $24.2M | $33.7M | $37.7M | -- | |
Operating Income | -$11.3M | $1.3M | $6.9M | $15.2M | -- | |
Net Interest Expenses | $400K | $939K | $277K | -- | -- | |
EBT. Incl. Unusual Items | -$11.2M | $561K | $5.6M | $15.4M | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$2.4M | $194K | $1M | $3.2M | -- | |
Net Income to Company | -$8.8M | $367K | $4.6M | $12.2M | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$8.8M | $367K | $4.6M | $12.2M | -- | |
Basic EPS (Cont. Ops) | -$0.84 | $0.02 | $0.43 | $1.12 | -- | |
Diluted EPS (Cont. Ops) | -$0.84 | $0.02 | $0.43 | $1.11 | -- | |
Weighted Average Basic Share | $42.2M | $42.5M | $43M | $43.5M | -- | |
Weighted Average Diluted Share | $42.2M | $42.6M | $43.4M | $44.3M | -- | |
EBITDA | -$5.2M | $7.2M | $12.4M | $21.1M | -- | |
EBIT | -$10.8M | $1.3M | $6.9M | $15.2M | -- | |
Revenue (Reported) | $122.8M | $157.1M | $185.5M | $209.9M | -- | |
Operating Income (Reported) | -$11.3M | $1.3M | $6.9M | $15.2M | -- | |
Operating Income (Adjusted) | -$10.8M | $1.3M | $6.9M | $15.2M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $59.5M | $14.7M | $18.3M | $16.9M | $21.6M | |
Short Term Investments | $5.5M | -- | -- | -- | -- | |
Accounts Receivable, Net | $17.4M | $27.6M | $24M | $44.4M | $35.5M | |
Inventory | $17.3M | $17.4M | $26.3M | $33.4M | $40M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $512K | $1.4M | $1.8M | $3.6M | $4.2M | |
Total Current Assets | $120.2M | $87.2M | $110.1M | $126.3M | $141.4M | |
Property Plant And Equipment | $17.7M | $33.3M | $33.8M | $39.4M | $57M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | $23.5M | $23.5M | $25.5M | $25.5M | |
Other Intangibles | -- | $30M | $27.5M | $32.5M | $30.3M | |
Other Long-Term Assets | $103K | $194K | $158K | $724K | $2.4M | |
Total Assets | $144.3M | $183.7M | $203.9M | $233.9M | $264.1M | |
Accounts Payable | $18M | $16.7M | $20.2M | $20.8M | $27.3M | |
Accrued Expenses | $4M | $6M | $6.4M | $6.7M | $4.3M | |
Current Portion Of Long-Term Debt | $21K | $2M | $2M | -- | -- | |
Current Portion Of Capital Lease Obligations | $46K | $1.1M | $1.1M | $1.3M | $1.3M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $43.6M | $59.4M | $86.2M | $118.2M | $136.2M | |
Long-Term Debt | -- | $16.4M | $9.7M | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $46.4M | $87.2M | $107M | $128.3M | $144.5M | |
Common Stock | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | |
Other Common Equity Adj | -$7.4M | -$6.5M | -$7.5M | -$7M | -$7M | |
Common Equity | $97.9M | $96.5M | $96.9M | $105.6M | $119.6M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $97.9M | $96.5M | $96.9M | $105.6M | $119.6M | |
Total Liabilities and Equity | $144.3M | $183.7M | $203.9M | $233.9M | $264.1M | |
Cash and Short Terms | $65M | $14.7M | $18.3M | $16.9M | $21.6M | |
Total Debt | $21K | $18.4M | $11.7M | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $59.5M | $14.7M | $18.3M | $16.9M | $21.6M | |
Short Term Investments | $5.5M | -- | -- | -- | -- | |
Accounts Receivable, Net | $17.4M | $27.6M | $24M | $44.4M | $35.5M | |
Inventory | $17.3M | $17.4M | $26.3M | $33.4M | $40M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $512K | $1.4M | $1.8M | $3.6M | $4.2M | |
Total Current Assets | $120.2M | $87.2M | $110.1M | $126.3M | $141.4M | |
Property Plant And Equipment | $17.7M | $33.3M | $33.8M | $39.4M | $57M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | $23.5M | $23.5M | $25.5M | $25.5M | |
Other Intangibles | -- | $30M | $27.5M | $32.5M | $30.3M | |
Other Long-Term Assets | $103K | $194K | $158K | $724K | $2.4M | |
Total Assets | $144.3M | $183.7M | $203.9M | $233.9M | $264.1M | |
Accounts Payable | $18M | $16.7M | $20.2M | $20.8M | $27.3M | |
Accrued Expenses | $4M | $6M | $6.4M | $6.7M | $4.3M | |
Current Portion Of Long-Term Debt | $21K | $2M | $2M | -- | -- | |
Current Portion Of Capital Lease Obligations | $46K | $1.1M | $1.1M | $1.3M | $1.3M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $43.6M | $59.4M | $86.2M | $118.2M | $136.2M | |
Long-Term Debt | -- | $16.4M | $9.7M | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $46.4M | $87.2M | $107M | $128.3M | $144.5M | |
Common Stock | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | |
Other Common Equity Adj | -$7.4M | -$6.5M | -$7.5M | -$7M | -$7M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $97.9M | $96.5M | $96.9M | $105.6M | $119.6M | |
Total Liabilities and Equity | $144.3M | $183.7M | $203.9M | $233.9M | $264.1M | |
Cash and Short Terms | $65M | $14.7M | $18.3M | $16.9M | $21.6M | |
Total Debt | $21K | $18.4M | $11.7M | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $2.4M | -$8.8M | $367K | $4.6M | $12.2M | |
Depreciation & Amoritzation | $1.9M | $5.6M | $6M | $5.4M | $5.9M | |
Stock-Based Compensation | $864K | $809K | $806K | $1.3M | $2M | |
Change in Accounts Receivable | -$5.9M | -$1.7M | -$12.6M | -$7.9M | -$4.8M | |
Change in Inventories | $5.2M | $3.5M | -$9.9M | -$6.2M | -$6.6M | |
Cash From Operations | -$1.7M | -$2.2M | $13.9M | $28.1M | $24.3M | |
Capital Expenditures | $2.2M | $2.3M | $3.7M | $9.2M | $19M | |
Cash Acquisitions | -- | -$60.3M | -- | -$6.8M | -$170K | |
Cash From Investing | $32.4M | -$57.1M | -$3.7M | -$16M | -$19.1M | |
Dividends Paid (Ex Special Dividend) | -$4.4M | -$3.5M | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $4.6M | $58.3M | $5M | $13M | -- | |
Long-Term Debt Repaid | -$4.6M | -$40M | -$11.3M | -$25.8M | -$320K | |
Repurchase of Common Stock | -$23K | -$41K | -$21K | -$58K | -$854K | |
Other Financing Activities | -- | -$271K | -$122K | -$993K | -- | |
Cash From Financing | -$4.5M | $14.4M | -$6.4M | -$13.4M | -$521K | |
Beginning Cash (CF) | $33M | $59.5M | $14.7M | $18.3M | $16.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $26.2M | -$44.9M | $3.7M | -$1.3M | $4.7M | |
Ending Cash (CF) | $59.5M | $14.7M | $18.3M | $16.9M | $21.6M | |
Levered Free Cash Flow | -$3.9M | -$4.5M | $10.2M | $18.9M | $5.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $388K | -$1.4M | -$481K | $1.3M | $4.4M | |
Depreciation & Amoritzation | $487K | $1.6M | $1.5M | $1.6M | $1.6M | |
Stock-Based Compensation | $43K | $210K | $224K | $277K | $753K | |
Change in Accounts Receivable | -$1.3M | $10.5M | $3.4M | -$7.3M | -$4.3M | |
Change in Inventories | $186K | $2.9M | -$3.1M | -$1.9M | -$999K | |
Cash From Operations | -$2.4M | $12.3M | $5M | $8.6M | -$3.6M | |
Capital Expenditures | $696K | $415K | $1.4M | $4M | $5.2M | |
Cash Acquisitions | -- | -$719K | -- | -- | -- | |
Cash From Investing | -$695K | -$1.1M | -$1.4M | -$4M | -$5.2M | |
Dividends Paid (Ex Special Dividend) | -$1.1M | $1K | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $28.5M | -- | -- | -- | |
Long-Term Debt Repaid | -$5K | -$38.8M | -$2.6M | -$3.1M | -$83K | |
Repurchase of Common Stock | -- | -- | $1K | -$1K | -- | |
Other Financing Activities | -- | -$121K | -- | -- | -- | |
Cash From Financing | -$1.1M | -$10.4M | -$2.6M | -$2.8M | $236K | |
Beginning Cash (CF) | $63.8M | $14M | $17.2M | $15.2M | $30M | |
Foreign Exchange Rate Adjustment | -$69K | -$5K | $4K | -$14K | $9K | |
Additions / Reductions | -$4.2M | $755K | $1M | $1.8M | -$8.5M | |
Ending Cash (CF) | $59.5M | $14.7M | $18.3M | $16.9M | $21.6M | |
Levered Free Cash Flow | -$3.1M | $11.9M | $3.6M | $4.6M | -$8.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $2.4M | -$8.8M | $367K | $4.6M | $12.2M | |
Depreciation & Amoritzation | $1.9M | $5.6M | $6M | $5.4M | $5.9M | |
Stock-Based Compensation | $864K | $809K | $806K | $1.3M | $2M | |
Change in Accounts Receivable | -$5.9M | -$1.7M | -$12.6M | -$7.9M | -$4.8M | |
Change in Inventories | $5.2M | $3.5M | -$9.9M | -$6.2M | -$6.6M | |
Cash From Operations | -$1.7M | -$2.2M | $13.9M | $28.1M | $24.3M | |
Capital Expenditures | $2.2M | $2.3M | $3.7M | $9.2M | $19M | |
Cash Acquisitions | -- | -$60.3M | -- | -$6.8M | -$170K | |
Cash From Investing | $32.4M | -$57.1M | -$3.7M | -$16M | -$19.1M | |
Dividends Paid (Ex Special Dividend) | -$4.4M | -$3.5M | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $4.6M | $58.3M | $5M | -- | -- | |
Long-Term Debt Repaid | -$4.6M | -$40M | -$11.3M | -$25.8M | -$320K | |
Repurchase of Common Stock | -$23K | -$41K | -$21K | -$58K | -$854K | |
Other Financing Activities | -- | -$271K | -$122K | -- | -- | |
Cash From Financing | -$4.5M | $14.4M | -$6.4M | -$13.4M | -$521K | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $26.2M | -$44.9M | $3.7M | -$1.3M | $4.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$3.9M | -$4.5M | $10.2M | $18.9M | $5.4M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$8.8M | $367K | $4.6M | $12.2M | -- | |
Depreciation & Amoritzation | $5.6M | $6M | $5.4M | $5.9M | -- | |
Stock-Based Compensation | $809K | $806K | $1.3M | $2M | -- | |
Change in Accounts Receivable | -$1.7M | -$12.6M | -$7.9M | -$4.8M | -- | |
Change in Inventories | $3.5M | -$9.9M | -$6.2M | -$6.6M | -- | |
Cash From Operations | -$2.2M | $13.9M | $28.1M | $24.3M | -- | |
Capital Expenditures | $2.3M | $3.7M | $9.2M | $19M | -- | |
Cash Acquisitions | -$60.3M | -- | -$6.8M | -$170K | -- | |
Cash From Investing | -$57.1M | -$3.7M | -$16M | -$19.1M | -- | |
Dividends Paid (Ex Special Dividend) | -$3.5M | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $58.3M | $5M | $13M | -- | -- | |
Long-Term Debt Repaid | -$40M | -$11.3M | -$25.8M | -$320K | -- | |
Repurchase of Common Stock | -$41K | -$21K | -$58K | -$854K | -- | |
Other Financing Activities | -$271K | -$122K | -$993K | -- | -- | |
Cash From Financing | $14.4M | -$6.4M | -$13.4M | -$521K | -- | |
Beginning Cash (CF) | $109.1M | $59M | $83.9M | $100.9M | -- | |
Foreign Exchange Rate Adjustment | $115K | -$208K | -$53K | -$30K | -- | |
Additions / Reductions | -$44.9M | $3.7M | -$1.3M | $4.7M | -- | |
Ending Cash (CF) | $64.3M | $62.5M | $82.6M | $105.6M | -- | |
Levered Free Cash Flow | -$4.5M | $10.2M | $18.9M | $5.4M | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.